Published in

Karger Publishers, Urologia Internationalis, 1(81), p. 29-35

DOI: 10.1159/000137637

Links

Tools

Export citation

Search in Google Scholar

Is There Any Clinical Parameter Able to Predict Prostate Cancer after Initial Diagnosis of Atypical Small Acinar Proliferation?

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

<i>Introduction:</i> Tissue samples from prostate biopsy may contain atypical small acinar proliferation (ASAP): present guidelines recommend a repeat biopsy policy. This study attempted to identify clinical patterns that help predict cancer detection at second biopsy. <i>Materials and Methods:</i> From 1999 to 2005, 1,274 patients underwent a prostate biopsy: in 5.9% ASAP was found, and patients underwent a second biopsy. Uni- and multivariate analysis compared the clinical patterns of cancer patients with the no cancer group at second biopsy. <i>Results:</i> Univariate analysis showed significant differences in PSA ratio density, prostate volume, final PSA values and ΔPSA; at multivariate logistic regression analysis, only PSA ratio (OR = 0.743, 95% CI 0.620–0.891) and prostate volume (OR = 0.960, 95% CI 0.924–0.998) were predictive of malignancy. <i>Conclusions:</i> In our experience, PSA ratio and prostate volume seem to be independent predictors of prostate cancer at re-biopsy.